|
Period 1
|
Period 2
|
Period 3
|
P*
|
---|
Group–n (%)
|
Men
|
6,643
|
(27.6)
|
2,640
|
(30.9)
|
2,582
|
(31.0)
|
<0.001
|
Women < 40 years old
|
13,851
|
(57.5)
|
4,867
|
(57.0)
|
4,681
|
(56.2)
| |
Women ≥40 years old
|
3,588
|
(14.9)
|
1,028
|
(12.1)
|
1,071
|
(12.8)
| |
CD4 count (cells/μL) - median [IQR]
|
In men
|
180 [71–341]
|
183 [74–335]
|
229 [100–386]
|
<0.001
|
In women <40 years old
|
307 [164–481]
|
288 [158–458]
|
349 [213–520]
|
<0.001
|
In women ≥40 years old
|
258 [135–432]
|
242 [119–419]
|
333 [161–522]
|
<0.001
|
Age (years)-median [IQR]
|
In men
|
36.5 [30.4-44.5]
|
34.8 [28.7-43.0]
|
34.5 [28.3-42.0]
|
<0.001
|
In women <40 years old
|
27.5 [23.4-32.6]
|
26.5 [22.5-31.2]
|
26.7 [22.4-31.6]
|
<0.001
|
In women ≥40 years old
|
46.8 [43.2-51.9]
|
46.9 [42.9-53.0]
|
48.0 [43.7-53.4]
|
<0.001
|
- IQR: Inter-Quartile Interval
- Period 1: January 1, 2007–March 31, 2010; Period 2: April 1, 2010–July 31, 2011; Period 3: August 1, 2011–September 15, 2012
- * p.value with Chi2 tests (for group) or Anova tests (for CD4 cells count and Age)
- HIV Hlabisa programme, KwaZulu-Natal, South Africa. 2007–2012